Xenon Pharmaceuticals Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Company Directory for Xenon Pharmaceuticals Inc.

Team Bitscale

31 Jan 2026 — 1 min read

Xenon Pharmaceuticals Inc.

Overview

Xenon Pharmaceuticals Inc. is a biopharmaceutical company based in Burnaby, British Columbia, focused on developing innovative therapeutics for neurological and psychiatric disorders. Founded in 1996, the company specializes in ion channel science, particularly targeting potassium and sodium channels to address conditions such as epilepsy, major depressive disorder, bipolar depression, and pain. It is publicly traded on NASDAQ under the ticker XENE.

The company's pipeline includes azetukalner, a Kv7 potassium channel opener currently in Phase 3 trials for epilepsy and mood disorders. Additionally, it is developing NBI-921352, a sodium channel inhibitor in Phase 1 trials for epilepsy, in collaboration with Neurocrine Biosciences. Xenon also has multiple early-stage programs targeting pain treatment, advancing its clinical trials and research initiatives in neuroscience.

Basic Information

Industry	research
Founded	1996
Revenue	$8.2M
Headquarters	3650 Gilmore Way, Burnaby, British Columbia, V5G 4W8, Canada
Languages	English
Alexa Ranking

Contact Details

Phone: +1 604-484-3300
Website: xenon-pharma.com
LinkedIn: linkedin.com/company/xenonpharma

Key Focus Areas & Initiatives

Drug discovery
Ion channels
Neurology
Epilepsy
Drug development
Neuroscience
Biotechnology
Biopharmaceuticals
Focal onset seizures
Major depressive disorder (MDD)
Psychiatry
Depression
Neuropsychiatry
Sodium channels
Potassium channels
Biotechnology research
Drug pipeline management
Neurological disease treatment
Ion channel research
Neurogenetics pharmaceutical
Clinical trials
Innovative neurotherapeutics
Clinical-stage drugs
Targeted ion channel therapy
Depression treatment
Bipolar disorder
Biopharmaceutical innovation
Neurological disorder treatments
Pharmaceuticals
Patient care

Technologies Used

AI
Amazon AWS
Google Tag Manager
Microsoft Office 365
Mobile Friendly
Nginx
Outlook
Remote
Route 53
Typekit
WordPress.org

Best Intent Data Tools in 2026: Ranked by Signal Type & Coverage

Most B2B pipelines fail because of poor timing, not poor targeting. An effective intent data tool helps you reach the right accounts when they are actively evaluating solutions, turning cold outreach into warm conversations. These platforms track behavioral breadcrumbs that prospects leave across the web, such as content downloads, competitor

RevOps Tools in 2026: Best Platform by Function

Revenue operations tools are the plumbing of high-performing B2B organizations: mostly invisible when they work, but painfully obvious when they do not. The adoption of a formal revenue operations model is accelerating, particularly among the highest-growth companies. This momentum reflects the tangible business outcomes of aligning people, processes, and technology

AI Email Marketing for B2B: Tools, Sequence & Deliverability Tips

B2B inboxes are brutal. Decision-makers receive a high volume of emails daily, and most outbound messages are dismissed in seconds. Batch-and-blast outreach stopped being effective years ago, yet many sales and marketing teams still use it because it is familiar. AI email marketing changes the math. Lean teams can ship

Top AI Software Companies For Revenue Teams to Know in 2026

AI’s impact on B2B sales has moved from hype to line-item outcomes. Generative AI now shows up in day-to-day revenue work, from research and list building to call analysis and forecasting. For revenue teams, that shift shows up everywhere. Each stage of the pipeline, from first-touch prospecting to closed-won